🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christine M. Bestvina

University of Chicago Medicine Comprehensive Cancer Center

ORCID: 0000-0001-7189-1590
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.109Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423
Top 72%
0.109DataRank
Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

Papers

Driven by 13 papers — median percentile 28. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9
N/A
11.9DataRank · unranked
1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial

Nature Medicine(2024)10.1038/s41591-023-02717-6
N/A
2.0DataRank · unranked
94 citations

Marwan Fakih, John H. Strickler, Rona Yaeger, Toshiki Masuishi, Edward Kim +14 more

Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004766
N/A
0.917DataRank · unranked
19 citations

Jovian Yu, Daniel J. Olson, Yuanyuan Zha, Apameh Pezeshk, Alexandra Cabanov +9 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420
N/A
0.787DataRank · unranked
189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7
N/A
0.769DataRank · unranked
168 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer

Clinical Lung Cancer(2022)10.1016/j.cllc.2022.04.004
N/A
0.662DataRank · unranked
19 citations

Xiaofei Wang, Christine M. Bestvina, Terence M. Williams, Greg Masters, Anurag Kumar Singh +10 more

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423
Top 72%
0.109DataRank
Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

The use of artificial intelligence with uncertainty estimation to predict lung cancer relapse from histopathology.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8549
N/A
0.104DataRank · unranked
1 citations

Sara Kochanny, Annie Zhu, Sagar Rakshit, Radhika Bansal, Melanie C. Bois +6 more

Chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9080
N/A
0DataRank · unranked
3 citations

Christina J. Falcon, Christine M. Bestvina, Dazhi Liu, Lauren A. Kaplanis, Clare Wilhelm +11 more

Delays in phases of care from identification to treatment of suspicious lung nodules

JTCVS Open(2025)10.1016/j.xjon.2025.01.006
N/A
0DataRank · unranked
1 citations

Rachel Nordgren, Aliya N. Husain, Aditya Juloori, Christine M. Bestvina, Rajat Thawani +10 more

Abnormalities on baseline chest imaging are risk factors for immune checkpoint inhibitor associated pneumonitis

Respiratory Medicine(2023)10.1016/j.rmed.2023.107330
N/A
0DataRank · unranked
9 citations

Renea Jablonski, Mary E. Strek, Christine M. Bestvina, Mei‐Yin C. Polley, Pankti Reid +1 more

What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231198446
N/A
0DataRank · unranked
7 citations

Jacobi Hines, Valter Torri, Luca Porcu, Jessica Donington, Christine M. Bestvina +5 more

Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.06.008
N/A
0DataRank · unranked
47 citations

Christina J. Falcon, Christine M. Bestvina, Dazhi Liu, Lauren A. Kaplanis, Clare Wilhelm +12 more